Print

Mylan Inc. (MYL) Schedules First Quarter 2014 Financial Results Conference Call And Live Webcast  
4/9/2014 6:14:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PITTSBURGH, April 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it will host a conference call and live webcast on Thursday, May 1, 2014, at 11 a.m. ET, to review the company's financial results for the first quarter ended March 31, 2014. Mylan will release its financial results on May 1, before the market opens.

The dial-in number to access the call is 800.514.4861 or 678.809.2405 for international callers. To access the live webcast, please log on to Mylan's website, mylan.com, at least 15 minutes before the event is scheduled to begin to register and download or install any necessary software. A replay of the webcast will be available at mylan.com/investors, for a limited time.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,300 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com.

SOURCE Mylan Inc.



Help employers find you! Check out all the jobs and post your resume.

//-->